NEOSPORIN®
(https://neosporin.com) 📸 Data Snapshot: May 30, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
There is a significant technical authority gap as the schema_json is null across the board, missing an opportunity to verify the brand via Organization or Product schema. While it references ‘doctors’ generically, there are no named experts, medical advisors, or researchers with digital footprints (Person schema) provided in the text.
The site makes definitive performance claims such as ‘kill bacteria and stop infection before it starts’ and ‘minimizing the appearance of scars’ without providing the specific mechanism of action or drug monograph data. The marketing tone is authoritative but relies on the user’s existing brand trust rather than real-world evidence presented on-page.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /first-aid-info/ | 20 | 0 |
| /products/ | 20 | 0 |
| /where-to-buy/ | 0 | 0 |
This page presents a snapshot of public data from NEOSPORIN®, captured on May 30, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to NEOSPORIN®: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://neosporin.com to view the most current version of its content and see directly what this company is about and what it offers.